|
|
Profile
|
Delegates :
Kazuo Suzuki |
|
Incorporated :
February 22 , 2012 |
Paid in Capital :
8 Million yen Funded by members in Chiba and Hiroshima |
Employees :
4 人 |
Address :
Inohana 1-8-15, Chuo-ku, Chiba, Japan CHIBA
〒260-0856
|
TEL/FAX :
*81-43-221-0831 / *81-43-221-0832 |
URL：
http://www.a-clip.jp/English/indexEN.html |
Attachment :
 Poster-English-121029.pdf [ 828.6KiB ] |
Mission/Background :
[Mission]
Base on research works on inflammation and infectious diseases under international collaborations of basic studies and clinical studies for over 30 years, we will innovate developing products of diagnostic and medicine for contribution to intractable diseases and infectious diseases in the world.
[Background]
The CEO Dr. Suzuki started to research on inflammation and infectious diseases in the National Institute of Health, Tokyo in 1970s.
1981 Studies on Innate Immunity and Kawasaki disease in Radiation Effects Research Foundation (Former ABCC), Hiroshima, Japan
April 1986 Chief of laboratory in National Institute of Health (Now, National Institute of Infectious Diseases), Tokyo, Japan
April 2007 Coordinator for Global Center of Excellence Program “Immunology”, Chiba University Graduate School of Medicine
Feb. 22, 2012 Establish A-CLIP Institute, Chiba, Japan
April 1st 2012 Start of A-CLIP Institute, Chiba, Japan
|
|
Technology & Business
|
Development of diagnostic markers and medicine in the field in Inflammation and Infectious diseases
1) Medicine for infection-induced inflammation
2) Synthetic IgG
3) detection kits for ANCA and Influenza virus
Topics:
1)【ANCA-Fast(TM) 】is the first product in the world
2) Cooperation of Clinical studies on Biomarkers and genetic analysis
3) International Collaborations
Collaboration with University, Research Institute, Company, and TLO
-Chiba University Graduate School of Medicine
-Chiba University School of Medicine, Hospital
-Kyoto University, iPS Institute
【ANCA-Fast(TM) 】is the first product in the world
Anti-Moesin antibody has been founded by Dr. Suzuki, who worked as a G-COE Professor in Chiba University, et al.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
ANCA-FAST(TM)
|
Preclinical
|
ANCA-Fast(TM) can detect 4 autoantibodies MPO-ANCA, Meosin-ANCA, PR3-ANCA and anti-GBM within 15 min using 5-20 microL compared
|
December 2012; Release of ANCA-Fast(TM)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
CURRENT ACTIVITIES
[2012]
Jun. 13 Venture Award by Chiba University, Chiba, Japan
Jul. 20 Himawari Venture Foundation Award, Chiba, Japan
Sep. 24 Mitsubishi UFJ Foundation Award, Tokyo, Japan
Nov. 19 Venture Cup Chiba 2012 Grand Prix
Dec. 1 Release of 【ANCA-Fast(TM)】
[2013]
Oct. 9-11 BioJapan2013, Exhibition and Presentation, Yokohama, Japan
Nov. 12 Certificate, Leader's session of the Tokyo metro area
|
|
Hot news
|
We will release ANCA-Fast(TM) for medical research in December 2012.
|
|
Alliance strategy
|
Alliance Request in the current situation
1. Quality control for large amount of a product 【ANCA-Fast(TM)】
We will sale 1,000,000 kits in Japan 10 million in the world.
2. Sales for home doctors
|
|
|